Sanofi said it would help supply up to 200 million doses of
Moderna's vaccine at its Ridgefield facility in New Jersey.
Financial details of the arrangement were not disclosed.
The deal marks Sanofi's third such agreement this year. In January,
Sanofi pledged to help supply over 125 million doses of a COVID-19
vaccine made by Pfizer and BioNTech from this summer.
A month later, it said it would fill and finish vials of Johnson &
Johnson's single-shot vaccine at a rate of approximately 12 million
doses per month.
[to top of second column] |
Sanofi said it was still
working on developing two COVID-19 vaccines, one
in partnership with Britain's GlaxoSmithkline
for which it has started new clinical trials
after disappointing early-stage results last
year, and another with U.S. company Translate
Bio.
(Reporting by Matthias Blamont; Editing by
Louise Heavens)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |